Twelve-month real-world outcomes of sparsentan in a multicentre Spanish IgA nephropathy cohort - Clara García-Carro; Antolina Rodríguez-Moreno; Lucía Cordero; María Vanessa Pérez-Gómez; Helena Marco Rusiñol; Enrique Pasache; Alejandro Morales; Rocío Zamora; Diego Parra; Juan Villa; Elena Guillén-Olmos; Verónica Coll-Brito; et al. (Clinical Kidney Journal, 2026)